Griffith University in Australia has partnered with vaccines manufacturing company Indian Immunologicals (IIL) to develop a Covid-19 vaccine.
The partners intend to create a live attenuated vaccine. They will use codon de-optimisation technology to alter the virus’ genome to reduce its replication efficiency in human cells, making it harmless.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
